Showing 341 - 353 results of 353 for search '"gastroenterology"', query time: 0.05s Refine Results
  1. 341

    Breast-feeding efficacy prognosis by digestive enzymes activity in newborns by G. A. Penzhoyan, G. Yu. Model’, G. F. Korotko

    Published 2018-08-01
    “…This potential acts as is gastroenterological criterion for breast-feeding readiness.…”
    Get full text
    Article
  2. 342

    New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review) by A. I. Martynov, A. A. Sheptulin, I. V. Mayev, A. N. Kazyulin, A. Ye. Karateev, A. V. Melekhov, L. K. Pal’gova, K. L. Raikhel’son

    Published 2020-05-01
    “…Rebamipid is a highly effective drug positively affecting various cytoprotection links, thus being suitable for the treatment and prevention of erosive and ulcerative lesions of the gastrointestinal tract, as well as gastroenterological diseases of various etiologies.Conflict of interest: The Expert Council meeting was supported by the Alium company.…”
    Get full text
    Article
  3. 343

    Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion by V. V. Tsukanov, M. F. Osipenko, E. V. Beloborodova, M. A. Livzan, I. B. Khlynov, S. A. Alekseenko, Yu. P. Sivolap, J. L. Tonkikh, A. V. Vasyutin

    Published 2023-11-01
    “…The closeness of the clinical manifestations and pathogenesis of NAFLD and ALD justifies attention to drugs with metabolic activity, which are recommended by the Russian Gastroenterological Association and Russian Scientific Liver Society for the treatment of these diseases. …”
    Get full text
    Article
  4. 344

    Diagnostic Algorithm for Joint Pain in Patients with Inflammatory Bowel Disorders by A. I. Dolgushina, G. M. Khusainova, O. B. Nesmeyanova, N. V. Kirsh, O. V. Solovieva, E. A. Bogdanova

    Published 2022-01-01
    “…A total of 349 IBD patients hospitalised for gastroenterological complaints at the Chelyabinsk Regional Clinical Hospital during 2017–2020 have been examined.Results. …”
    Get full text
    Article
  5. 345

    Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare by Yu. A. Kucheryavy, T. L. Lapina, M. A. Livzan, M. F. Osipenko

    Published 2015-12-01
    “…According to the Clinical guidelines of the Russian gastroenterological association and abdominal pain management algorithm at outpatient reception, the doctor on the basis of interviewing, inspection and physical data first of all should exclude acute abdominal diseases (acute pain, parietal pain) requiring urgent examination by the surgeon or gynecologist and subsequent hospitalization. …”
    Get full text
    Article
  6. 346

    Chronic inflammatory bowel diseases: the course and treatment methods in Russian Federation (Results of multicenter population-based one-stage observational study) by L. . Khalif, M. V. Shapina, A. O. Golovenko, Ye. A. Belousova, Ye. Yu. Chashkova, A. V. Lakhin, O. V. Knyazev, A. Yu. Baranovsky, N. N. Nikolayeva, A. V. Tkachev

    Published 2018-08-01
    “…The clinical data, treatment methods, laboratory tests results and the rate of adverse effects for patients with inflammatory bowel diseases (IBD) from 8 gastroenterological centers were obtained. Severity grade was estimated by a doctor. …”
    Get full text
    Article
  7. 347
  8. 348
  9. 349

    Helicobacter pylori infection diagnostics and choice of eradication treatment: results of inquiry of doctors from different regions of Russian Federation by N. N. Dekhnich, R. S. Kozlov, O. A. Sablin, Ye. A. Prischepova

    Published 2018-08-01
    “…Of 241 described antihelicobacter first-line treatment modes 49.8% of respondents checked completely adequate treatment in accordance to the Russian Gastroenterological Association (RGA) guidelines. Of specified modes mainly clarithromycinbased standard triple therapy, including combination to the bismuth agent was mentioned. …”
    Get full text
    Article
  10. 350

    Biomarkers of gastric atrophy at stomach cancer by A. V. Belkovets, S. A. Kurilovich., Yu. I. Ragino, L. V. Scherbakova, O. B. Cheremisina, N. V. Cherdyntseva, N. A. Andryushina, M. I. Voyevoda

    Published 2018-08-01
    “…All patients underwent interviewing the questionnaire concerning smoking and alcohol consumption, presence of gastroenterological symptoms and family history. Blood serum samples were analyzed using ELISA test kits «GastroPanel» («Biohit Plc», Finland). …”
    Get full text
    Article
  11. 351

    Pain in pancreatitis: issue and ways out by A. V. Okhlobystin

    Published 2012-02-01
    “…Chronic pancreatitis is characterized by resistant pain in comparison to other gastroenterological diseases. Abdominal pain determines quality of life of CP patient to the highest degree of all other symptoms. …”
    Get full text
    Article
  12. 352

    Psychological and autonomous nervous system features of functional gastric dyspepsia and irritable bowel syndrome, duloxetine treatment efficacy by A. P. Pogromov, G. M. Dyukova, M. L. Leonova

    Published 2012-06-01
    “…At comparative analysis of gastroenterological symptoms in FGID and OGID patients in general it was revealed, that for majority of them no essential difference between organic and functional groups exits. …”
    Get full text
    Article
  13. 353

    Dynamics of Somatic and Comorbid Mental Disorders (Distress, Anxiety, Somatisation and Depression) in Patients with Irritable Bowel Syndrome during Therapy with Alimemazine: Result... by V. T. Ivashkin, O. Z. Okhlobystina, M. V. Mayevskaya, O. S. Shifrin, Z. A. Mamieva, Yu. E. Azimova

    Published 2019-01-01
    “…It is shown that the application of alimemazine (Teraligen®) in patients with IBS and concomitant FD associated with comorbid mental disorders (distress, anxiety, somatisation and depression) reduces gastroenterological (somatic) and mental (affective, somatoform) symptoms, improves the patients’ state of health, thus being confirmed as effective and safe.…”
    Get full text
    Article